AMC-061 Response Evaluation Form (R61) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747
- 8/26/12 8/26/12 -
- 6/24/17 6/24/17 - Martin Dugas
June 24, 2017
DOI:To request one please log in.
License :Creative Commons BY 4.0
This form is to be updated at each response assessment time point defined in the protocol. Please see protocol for guidelines for response evaluation
- StudyEvent: AMC-061 Response Evaluation Form (R61)